Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs

ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by... Neurol Ther (2018) 7:103–128 https://doi.org/10.1007/s40120-018-0094-z ORIGINAL RESEARCH ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 3 Ob1)F1 Mice by Induction of IL-10-Secreting iTregs . . . Adriano Luı´s Soares De Souza Stefan Rudin Rui Chang . . . . Keith Mitchell Timothy Crandall Shuning Huang Ji-Kyung Choi . . . Shinji L. Okitsu Danielle L. Graham Blake Tomkinson Tammy Dellovade Received: January 8, 2018 / Published online: March 14, 2018 The Author(s) 2018. This article is an open access publication humanized (DR2 9 Ob1)F1 mouse in a dose- ABSTRACT dependent fashion. Methods and Results: Our study extends these Introduction: Antigen-specific immunotherapy observations to show that subcutaneous treat- could provide a targeted approach for the ment with 100 lg of ATX-MS-1467 after induc- treatment of multiple sclerosis that removes the tion of EAE in the same mouse model reversed need for broad-acting immunomodulatory established clinical disability (p \ 0.0001) and drugs. ATX-MS-1467 is a mixture of four pep- histological markers of inflammation and tides identified as the main immune-dominant demyelination (p \ 0.001) compared with disease-associated T-cell epitopes in myelin vehicle-treated animals; furthermore, in longi- basic protein (MBP), an autoimmune target for tudinal magnetic resonance imaging analyses, activated http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Neurology and Therapy Springer Journals

ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs

Loading next page...
1
 
/lp/springer_journal/atx-ms-1467-induces-long-term-tolerance-to-myelin-basic-protein-in-dr2-OfG00lliS7

References (44)

Publisher
Springer Journals
Copyright
Copyright © 2018 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Neurology
ISSN
2193-8253
eISSN
2193-6536
DOI
10.1007/s40120-018-0094-z
Publisher site
See Article on Publisher Site

Abstract

Neurol Ther (2018) 7:103–128 https://doi.org/10.1007/s40120-018-0094-z ORIGINAL RESEARCH ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 3 Ob1)F1 Mice by Induction of IL-10-Secreting iTregs . . . Adriano Luı´s Soares De Souza Stefan Rudin Rui Chang . . . . Keith Mitchell Timothy Crandall Shuning Huang Ji-Kyung Choi . . . Shinji L. Okitsu Danielle L. Graham Blake Tomkinson Tammy Dellovade Received: January 8, 2018 / Published online: March 14, 2018 The Author(s) 2018. This article is an open access publication humanized (DR2 9 Ob1)F1 mouse in a dose- ABSTRACT dependent fashion. Methods and Results: Our study extends these Introduction: Antigen-specific immunotherapy observations to show that subcutaneous treat- could provide a targeted approach for the ment with 100 lg of ATX-MS-1467 after induc- treatment of multiple sclerosis that removes the tion of EAE in the same mouse model reversed need for broad-acting immunomodulatory established clinical disability (p \ 0.0001) and drugs. ATX-MS-1467 is a mixture of four pep- histological markers of inflammation and tides identified as the main immune-dominant demyelination (p \ 0.001) compared with disease-associated T-cell epitopes in myelin vehicle-treated animals; furthermore, in longi- basic protein (MBP), an autoimmune target for tudinal magnetic resonance imaging analyses, activated

Journal

Neurology and TherapySpringer Journals

Published: Mar 14, 2018

There are no references for this article.